Impaired Glucose Tolerance [clinicaltrials_resource:4eda41214ee3b51e5d76b109c116794a]
clinicaltrials:NCT00067626The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial [clinicaltrials:NCT00095654]A Lifestyle and Combination Medication Therapy Diabetes Prevention Study [clinicaltrials:NCT00116922]clinicaltrials:NCT00122447The Study of Atherosclerosis With Ramipril and Rosiglitazone [clinicaltrials:NCT00140647]Assessment of an Alpha-Glucosidase Inhibitor to Block Cardiac Events in Patients With Myocardial Infarction and IGT (ABC Study) [clinicaltrials:NCT00212017]Effective Endurance Training in Metabolic Syndrome [clinicaltrials:NCT00218998]Cognitive Effects of Aerobic Exercise for IGT Adults [clinicaltrials:NCT00220441]Actos Now for Prevention of Diabetes (ACT NOW) [clinicaltrials:NCT00220961]Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance [clinicaltrials:NCT00241072]Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults [clinicaltrials:NCT00352287]11ß-HSD1 and Metabolic Syndrome [clinicaltrials:NCT00370305]Impact of 3-Year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study [clinicaltrials:NCT00381186]clinicaltrials:NCT00402194Telmisartan and Losartan in Hypertensive IGT [clinicaltrials:NCT00407862]clinicaltrials:NCT00413335Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes [clinicaltrials:NCT00417950]clinicaltrials:NCT00456885The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients [clinicaltrials:NCT00472342]clinicaltrials:NCT00476710To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients [clinicaltrials:NCT00489229]Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease [clinicaltrials:NCT00510588]Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery Disease [clinicaltrials:NCT00510705]Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth [clinicaltrials:NCT00536250]clinicaltrials:NCT00546728Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin Resistance [clinicaltrials:NCT00564551]Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism [clinicaltrials:NCT00573781]clinicaltrials:NCT00594399clinicaltrials:NCT00625781clinicaltrials:NCT00627744Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients [clinicaltrials:NCT00652379]clinicaltrials:NCT00663000Physical Exercise Versus Rosiglitazone in CAD and Prediabetes [clinicaltrials:NCT00675740]clinicaltrials:NCT00685594Anti-Inflammatory Effects of Pioglitazone [clinicaltrials:NCT00722631]clinicaltrials:NCT00724542Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance [clinicaltrials:NCT00733174]clinicaltrials:NCT00829660The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism) [clinicaltrials:NCT00841867]clinicaltrials:NCT00845182
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Impaired Glucose Tolerance [clinicaltrials_resource:4eda41214ee3b51e5d76b109c116794a]
Bio2RDF identifier
4eda41214ee3b51e5d76b109c116794a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4eda41214ee3b51e5d76b109c116794a
identifier
clinicaltrials_resource:4eda41214ee3b51e5d76b109c116794a
title
Impaired Glucose Tolerance
@en
label
Impaired Glucose Tolerance [clinicaltrials_resource:4eda41214ee3b51e5d76b109c116794a]
@en